CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC
X. Yuan, X. Hao, H. L. Chan, N. Zhao, D. A. Pedroza, F. Liu, K. Le, A. J. Smith, S. J. Calderon, N. Lieu, M. J. Soth, P. Jones, X. H.- F. Zhang, J. M. Rosen
CBP/P300 BRD inhibition reduces neutrophil accumulation and enhances antitumor immunity in neutrophil-enriched TNBC, improving responses to standard therapies.
bioRxiv · Apr 25, 2024 · PreprintCancer Biology